Advertisement Pharmaceutical Business review - Page 711 of 5261 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 19, 2026

MSD and Mayo Clinic team up to advance AI in drug development

Merck & Co (MSD) and Mayo Clinic have entered a research and development collaboration to utilise AI, advanced analytics, and multimodal clinical data in support of drug discovery and precision medicine.

Continue
The partnership gives MSD access to datasets, registries, biorepositories, AI tools, analytics, and scalable solutions via Mayo Clinic. Credit: ART STOCK CREATIVE / Shutterstock.com.
February 19, 2026

Novartis enters licensing agreement with UNP for peptide therapeutics

The partnership combines UNP’s AI-driven macrocycle platform with Novartis’s commercialisation expertise. Credit: Gorodenkoff / Shutterstock.com.
February 18, 2026

J&J’s Rybrevant Faspro gains FDA approval for new dosing in NSCLC

The PALOMA-2 study showed monthly Rybrevant Faspro with Lazcluze achieved high response in untreated advanced EGFR-mutated NSCLC. Credit: Arif biswas/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Evogene and QUT partner on AI-based cancer therapies
  2. Teijin and Aska Pharmaceutical agree for gynaecological drug development
  3. ExCellThera secures German NUB Status 1 listing for Zemcelpro
  4. Immunic secures $400m fund to support commercial-stage development
  5. Ampersand Capital acquires Purna Pharmaceuticals

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography